COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,587 Articles (22,415 medRxiv, 8,172 bioRxiv)

Most recent first Previous |  Page 547: Articles 5461-5470  | Next

Real-time inactivation of airborne SARS-CoV-2 using ultraviolet-C
Koutras, C., Wade, R. L.
10.1101/2022.10.04.510919 — Posted: 2022-10-05
A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteers
Imsuwansri, T., Jongthitinon, T., Pojdoung, N., Meesiripan, N., Sakarin, S., Boonkrai, C., Wongtangprasert, T., Phakham, T., Audomsun, T., Attakitbancha, C., Saelao, P., Muanwien, P., Tian, M. T., Tongchusak, S., Sangruji, B., Wannigama, D. L., Sawangmake, C., Rodprasert, W., Le, Q. D., Purbantoro, S. D., Vasuntrarak, K., Nantavisai, S., Sirilak, S., Uppapong, B., Sapsutthipas, S., Trisiriwanich, S., Somporn, T., Usoo, A., Mingngamsup, N., Phumiamorn, S., Aumklad, P., Arunprasert, K., Patrojanasophon, P., Opanasopit, P., Pesirikan, N., Nitisaporn, L., Pitchayakorn, J., Narkthong, T., Mahong, B., Chaiyo, K., Srisuthisamphan, K., Viriyakitkosol, R., Aeumjaturapat, S., Jongkaewwattana, A., Bunnag, S., Pisitkun, T.
10.1101/2022.10.04.22280574 — Posted: 2022-10-05
Optimal metabolic states in cells
Liebermeister, W.
10.1101/483867 — Posted: 2022-10-05
Home working and its association with social and mental wellbeing at different stages of the COVID-19 pandemic: Evidence from seven UK longitudinal population surveys.
Wels, J., Wielgoszewska, B., Moltrecht, B., Booth, C., Green, M. J., Hamilton, O. K., Demou, E., Di Gessa, G., Huggins, C., Zhu, J., Santorelli, G., Silverwood, R., Kopasker, D., Shaw, R. J., Hughes, A., Patalay, P., Steves, C., Chaturvedi, N., Porteous, P. D., Rhead, R., Katikireddi, S. V., Ploubidis, G.
10.1101/2022.10.03.22280412 — Posted: 2022-10-04
Effectiveness of nirmatrelvir-ritonavir against hospital admission: a matched cohort study in a large US healthcare system
Lewnard, J. A., Malden, D., Hong, V., Puzniak, L., Kim, J. S., Shaw, S. F., Takhar, H., Jodar, L., McLaughlin, J. M., Tartof, S. Y.
10.1101/2022.10.02.22280623 — Posted: 2022-10-04
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions and immunogenicity of PEG-containing Covid-19 vaccines
Kozma, G. T., Meszaros, T., Berenyi, P., Facsko, R., Patko, Z., Olah, C. Z., Nagy, A., Fulop, T. G., Glatter, K. A., Radovits, T., Merkely, B., Szebeni, J.
10.1101/2022.10.03.22280227 — Posted: 2022-10-04
Impact of vaccination on COVID-19-associated admissions to critical care in England: a population cohort study of linked data
Harrison, D. A., Watkinson, P. J., Doidge, J. C., Shankar-Hari, M., Mouncey, P. R., Patone, M., Coupland, C. A. C., Hippisley-Cox, J., Rowan, K. M.
10.1101/2022.10.03.22280649 — Posted: 2022-10-04
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression
Bobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., Issa, H., Cheng, B., Abu-Raddad, L. J., Buckeridge, D. L., Van Kerkhove, M., Piechotta, V., Higdon, M. M., Wilder-Smith, A., Bergeri, I., Feikin, D., Arora, R. K., Patel, M. K., Subissi, L.
10.1101/2022.10.02.22280610 — Posted: 2022-10-04
Population-level relative effectiveness of the COVID-19 vaccines and the contribution of naturally acquired immunity
Shioda, K., Chen, Y., Collins, M. H., Lopman, B.
10.1101/2022.10.04.22280689 — Posted: 2022-10-04
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - Implications for Long COVID?
Haunhorst, S., Bloch, W., Javelle, F., Krueger, K., Baumgart, S., Drube, S., Lemhoefer, C., Reuken, P., Stallmach, A., Mueller, M., Zielinski, C. E., Pletz, M. W., Gabriel, H. H. W., Puta, C.
10.1101/2022.10.04.22280642 — Posted: 2022-10-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).